These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7471603)

  • 1. Dynamic interaction between disulfiram and separated enantiomorphs of racemic warfarin.
    O'Reilly RA
    Clin Pharmacol Ther; 1981 Mar; 29(3):332-6. PubMed ID: 7471603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans.
    O'Reilly RA; Trager WF; Rettie AE; Goulart DA
    Clin Pharmacol Ther; 1987 Sep; 42(3):290-4. PubMed ID: 3621782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The stereoselective interaction of warfarin and metronidazole in man.
    O'Reilly RA
    N Engl J Med; 1976 Aug; 295(7):354-7. PubMed ID: 934223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective interaction of sulfinpyrazone with racemic warfarin and its separated enantiomorphs in man.
    O'Reilly RA
    Circulation; 1982 Jan; 65(1):202-7. PubMed ID: 7053283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticrynafen-racemic warfarin interaction: hepatotoxic or stereoselective?
    O'Reilly RA
    Clin Pharmacol Ther; 1982 Sep; 32(3):356-61. PubMed ID: 7105625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative interaction of cimetidine and ranitidine with racemic warfarin in man.
    O'Reilly RA
    Arch Intern Med; 1984 May; 144(5):989-91. PubMed ID: 6324710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of secobarbital with warfarin pseudoracemates.
    O'Reilly RA; Trager WF; Motley CH; Howald W
    Clin Pharmacol Ther; 1980 Aug; 28(2):187-95. PubMed ID: 7398186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative interaction of sulfinpyrazone and phenylbutazone with racemic warfarin: alteration in vivo of free fraction of plasma warfarin.
    O'Reilly RA; Goulart DA
    J Pharmacol Exp Ther; 1981 Dec; 219(3):691-4. PubMed ID: 7299692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective interaction of phenylbutazone with [12C/13C]warfarin pseudoracemates in man.
    O'Reilly RA; Trager WF; Motley CH; Howald W
    J Clin Invest; 1980 Mar; 65(3):746-53. PubMed ID: 7354137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racemic warfarin and trimethoprim-sulfamethoxazole interaction in humans.
    O'Reilly RA; Motley CH
    Ann Intern Med; 1979 Jul; 91(1):34-6. PubMed ID: 464451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of the stereoselective interaction between miconazole and racemic warfarin in human subjects.
    O'Reilly RA; Goulart DA; Kunze KL; Neal J; Gibaldi M; Eddy AC; Trager WF
    Clin Pharmacol Ther; 1992 Jun; 51(6):656-67. PubMed ID: 1611805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The warfarin-sulfinpyrazone interaction: stereochemical considerations.
    Toon S; Low LK; Gibaldi M; Trager WF; O'Reilly RA; Motley CH; Goulart DA
    Clin Pharmacol Ther; 1986 Jan; 39(1):15-24. PubMed ID: 3943265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective interaction of trimethoprim-sulfamethoxazole with the separated enantiomorphs of racemic warfarin in man.
    O'Reilly RA
    N Engl J Med; 1980 Jan; 302(1):33-5. PubMed ID: 7350395
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative pharmacokinetics of coumarin anticoagulants XXXV: Examination of possible pharmacokinetic interaction between (R)-(+)- and (S)-(--)-warfarin in humans.
    Levy G; O'Reilly RA; Wingard LB
    J Pharm Sci; 1978 Jun; 67(6):867-8. PubMed ID: 660478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of the warfarin-rifampin drug interaction in humans.
    Heimark LD; Gibaldi M; Trager WF; O'Reilly RA; Goulart DA
    Clin Pharmacol Ther; 1987 Oct; 42(4):388-94. PubMed ID: 3665337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.
    Lewis RJ; Trager WF; Chan KK; Breckenridge A; Orme M; Roland M; Schary W
    J Clin Invest; 1974 Jun; 53(6):1607-17. PubMed ID: 4830225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefotetan-induced disulfiram-type reactions and hypoprothrombinemia.
    Kline SS; Mauro VF; Forney RB; Freimer EH; Somani P
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1328-31. PubMed ID: 3479045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of sodium warfarin and disulfiram (antabuse) in man.
    O'Reilly RA
    Ann Intern Med; 1973 Jan; 78(1):73-6. PubMed ID: 4682311
    [No Abstract]   [Full Text] [Related]  

  • 19. Spironolactone and warfarin interaction.
    O'Reilly RA
    Clin Pharmacol Ther; 1980 Feb; 27(2):198-201. PubMed ID: 7353340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of warfarin enantiomers: a search for intrasubject correlations.
    Wingard LB; O'Reilly RA; Levy G
    Clin Pharmacol Ther; 1978 Feb; 23(2):212-7. PubMed ID: 620483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.